1-11 of 11
Mariapaola Fina
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treosulfan Plus Fludarabine (TTF10) As Preparative Regimen before Haploidentical Trasplant in Elderly Patients with Acute Myeloid Leukemia

Vincenzo Federico, Rosella Matera, Dalila Salvatore, Filippo Antonio Canale, Emanuela Merla, Daniela Valente, Corinne Contento, Giulia Campagna, Anna Rita Messa, Doriana Vaddinelli, Annalisa Natale, Mariapaola Fina, Amalia Tarantino, Nadia Quarta, Davide Seripa, Tiziana Grassi, Stella Santarone, Angelo Michele Carella, Massimo Martino, Nicola Di Renzo
Journal: Blood
Blood (2024) 144 (Supplement 1): 7294.
https://doi.org/10.1182/blood-2024-208595
Published: 2024
Journal Articles

Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.

Vittorio Stefoni, Alessandro Broccoli, Lapo Alinari, Valentina Ambrosini, Enrico Derenzini, Stefano Fanti, Mariapaola Fina, Letizia Gandolfi, Enrica Marchi, Cinzia Pellegrini, Federica Quirini, Pier Luigi Zinzani, Michele Baccarani
Journal: Blood
Blood (2009) 114 (22): 1659.
https://doi.org/10.1182/blood.V114.22.1659.1659
Published: 2009
Journal Articles

A Phase II Trial of Rituximab-CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, Mariapaola Fina, Monica Tani, Vittorio Stefoni, Letizia Gandolfi, Alessandro Broccoli, Cinzia Pellegrini, Enrico Derenzini, Giuseppe Rossi, MD, Emanuele Angelucci, Gianluca Gaidano, Maria Concetta Petti, Maurizio Martelli, Umberto Vitolo, Stefano Fanti, Michele Baccarani
Journal: Blood
Blood (2009) 114 (22): 2720.
https://doi.org/10.1182/blood.V114.22.2720.2720
Published: 2009
Journal Articles

A Phase II Trial of R-FM (Rituximab, Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan ( 90 Y-IT) for Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, Monica Tani, Alessandro Broccoli, Enrico Derenzini, Alessandro Pulsoni, Amalia De Renzo, Stefano Fanti, Mariapaola Fina, Letizia Gandolfi, Cinzia Pellegrini, Vittorio Stefoni, Michele Baccarani
Journal: Blood
Blood (2009) 114 (22): 3743.
https://doi.org/10.1182/blood.V114.22.3743.3743
Published: 2009
Journal Articles

FDG-PET in the Serial Assessment of Patients with Lymphoma in Complete Remission.

Pier Luigi Zinzani, MD, PhD, Vittorio Stefoni, MD, Valentina Ambrosini, MD, Enrico Derenzini, MD, Gerardo Musuraca, MD, Enrica Marchi, MD, Lapo Alinari, MD, Mariapaola Fina, MD, Monica Tani, MD, Cinzia Pellegrini, MD, Stefano Fanti, MD, Michele Baccarani, MD
Journal: Blood
Blood (2007) 110 (11): 216.
https://doi.org/10.1182/blood.V110.11.216.216
Published: 2007
Journal Articles

Phase II Study of Proteasome Inhibitor Bortezomib (Velcade®) in Patients with Relapsed/Refractory T-Cell Lymphoma: Preliminary Results.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Gerardo Musuraca, MD, Vittorio Stefoni, MD, Enrica Marchi, MD, Mariapaola Fina, MD, Michele Baccarani, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2462.
https://doi.org/10.1182/blood.V108.11.2462.2462
Published: 2006
Journal Articles

A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Stefano Fanti, MD, Vittorio Stefoni, MD, Gerardo Musuraca, MD, Paolo Castellucci, MD, Enrica Marchi, MD, Mariapaola Fina, MD, Michele Baccarani, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2431.
https://doi.org/10.1182/blood.V108.11.2431.2431
Published: 2006
Journal Articles

A Phase II Trial of FM (Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Indolent Non-Follicular Lymphoma Patients.

Pier Luigi Zinzani, MD, PhD, Monica Tani, MD, Stefano Fanti, MD, Gerardo Musuraca, MD, Alessio Perrotti, MD, Umberto Vitolo, MD, Mariapaola Fina, MD, Barbara Botto, MD, Enrica Marchi, MD, Giulia Benevolo, MD, Vittorio Stefoni, MD, Michele Baccarani, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2478.
https://doi.org/10.1182/blood.V108.11.2478.2478
Published: 2006
Journal Articles

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, Monica Tani, Vittorio Stefoni, Lapo Alinari, Enrica Marchi, Mariapaola Fina, Michele Baccarani
Journal: Blood
Blood (2005) 106 (11): 4763.
https://doi.org/10.1182/blood.V106.11.4763.4763
Published: 2005
Journal Articles

Report of a Phase II Study of Proteasome Inhibitor Bortezomib (Velcade) in Patients with Relapsed or Refractory T-Cell Lymphoma.

Pier Luigi Zinzani, Monica Tani, Vittorio Stefoni, Lapo Alinari, Enrica Marchi, Mariapaola Fina, Michele Baccarani
Journal: Blood
Blood (2005) 106 (11): 4764.
https://doi.org/10.1182/blood.V106.11.4764.4764
Published: 2005
Journal Articles

A Phase II Trial of CHOP Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin) for Previously Untreated Elderly Diffuse Large B-Cell Lymphoma (DLBCL) Patients.

Pier Luigi Zinzani, Monica Tani, Vittorio Stefoni, Lapo Alinari, Enrica Marchi, Mariapaola Fina, Michele Baccarani
Journal: Blood
Blood (2005) 106 (11): 4765.
https://doi.org/10.1182/blood.V106.11.4765.4765
Published: 2005